Bill Gates has funded a Dutch medical center that is developing mosquito vaccines that have been shown to infect human blood cells.
An unusual experiment funded by the Bill & Melinda Gates Foundation has developed a new vaccination strategy using mosquito bites as a vector to research a “next-generation” malaria vaccine.
The experiment, conducted by scientists at Leiden University Medical Center (LUMC) in the Netherlands, was recently published in the New England Journal of Medicine.
The researchers explained how they used mosquito bites to deliver a short-lived malaria vaccine containing genetically modified malaria parasites.
“We conducted a double-blind, controlled clinical trial to evaluate the safety, side effect profile, and efficacy of mosquito-borne immunization with a second-generation genetically attenuated parasite (GA2)—a mei2 single knockout P. falciparum parasite NF54 (sporozoite form) with prolonged liver-stage development,” the researchers explained.
The parasite Plasmodium falciparum (P. falciparum) causes malaria in humans.
The approach aimed to boost immunity through mosquito bites using genetically modified parasites to induce and stop malaria infection.
Initially, the researchers developed two types of malaria parasites, GA1 and GA2.
GA1 was supposed to stop development “approximately 24 hours after infection in humans,” but it turned out to have limited efficacy, leading to the development of GA2.
GA2 was “designed to stop development approximately six days after infection, during a key phase in which the parasites multiply in human liver cells.”
The experiment involved two phases.
In phase A, participants were “exposed to bites from 15 or 50 infected mosquitoes.”
In phase B, “healthy adults who had never had malaria were randomly assigned to receive 50 bites from mosquitoes vaccinated with GA2, a previous parasite (GA1), or a placebo (uninfected mosquitoes).
Strikingly, the researchers only monitored infections for 25 days, meaning that later infections were not recorded.
In addition, 20% of participants in phase B had elevated levels of troponin T—a biomarker of heart damage or stress, which raises concerns about potential heart damage.
However, the researchers said that these values were “unrelated to the study intervention,” without explaining in detail how they reached this conclusion.
COVID critic Dr. Richard Bartlett criticized the study’s short observation period and called for more comprehensive long-term data.
“The study raises significant concerns,” Dr. Bartlett said. “Just a few weeks of observation is not enough to assess long-term safety or efficacy. You would need at least six months to a year to monitor parasitic infections and potential complications. Where are the long-term data? Without that, late effects or complications cannot be adequately assessed.”
He stressed that the elevated T levels are “extremely concerning.”
“Troponin is a specific marker of heart damage, not liver damage,” he said. “This suggests potential heart damage that has not been adequately investigated.” This safety signal cannot be ignored.”
The Bill & Melinda Gates Foundation’s signature is clearly visible in this study.
In the same month of publication, LUMC received a $2,287,871 grant from the Gates Foundation to develop “next-generation malaria vaccine candidates.”
During the COVID pandemic, critics of experimental mRNA vaccines were censored and vilified.
Now, attention seems to be shifting to mosquito bites as a possible route of vaccine delivery, perhaps to avoid informed consent in future pandemic plans.
Source: https://www.infowars.com/posts/bill-gates-linked-vaccine-delivered-through-mosquito-bite-carries-bioengineered-malaria-causing-parasite
